Completed the Pharmacokinetic Study of HIBOR® (Bemiparin Sodium)

Lee's Pharmaceutical Holdings Limited (GEM Stock: 8221: Website: www.leespharm.com ) today announced that the Group has successfully completed the clinical study on Hibor® (Bemiparin Sodium), to evaluate the pharmacokinetic characteristics of single injection of Bemiparin and repeat injections of Bemiparin in healthy Chinese volunteers.

The release as fetched from its publisher. leespharm.com ↗